LABORATORY CORP OF AMERICA HOLDINGS
Labcorp, a global leader in laboratory services, is a North Carolina-based company with over 67,000 employees and operations in more than 100 countries. The company operates under two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). Labcorp's mission is to provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. The company generated revenues of $12,161.6 million, diluted earnings per share from continuing operations of $4.33, and had a total operating cash flow from continuing operations of $1,202.3 million for the year ended December 31, 2023. Labcorp's business strategy includes expanding its role in the healthcare market by strengthening its positions across its portfolio of capabilities, growing strategic opportunities, and differentiating its unique offerings. The company is focused on two near-term strategic opportunities for growth: becoming the partner of choice for health systems and local and regional laboratories, and leading in the development, licensing, and scaling of specialty testing including companion diagnostics. The company's Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing, while the Biopharma Laboratory Services segment consists of Early Development Research Laboratories and Central Laboratory Services. Labcorp worked on 90% of the new drugs approved by the FDA in 2023 and performed over 600 million tests for patients worldwide. The company's website is www.labcorp.com, and its stock is traded on the New York Stock Exchange under the ticker symbol LH.